ENTA Competitors & Alternatives
Compare Enanta Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
ENTA
Main Stock$13.60
Tradestie Score
58
Market Cap
$226.82M
Revenue Growth
0.2%
Analyst Upside
+55.7%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ATXS
Astria Therapeutics, Inc. Common Stock
|
$12.58
|
$425.52M | - | 58 | Compare |
|
ALMS
Alumis Inc. Common Stock
|
$26.95
|
$422.50M | - | 61 | Compare |
|
DRUG
Bright Minds Biosciences Inc. Common Stock
|
$74.85
|
$410.79M | - | 57 | Compare |
|
FDMT
4D Molecular Therapeutics, Inc. Common Stock
|
$11.54
|
$407.71M | - | 56 | Compare |
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$13.91
|
$386.68M | - | 64 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$7.05
|
$382.04M | - | 53 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$12.42
|
$371.64M | - | 63 | Compare |
|
CAPR
Capricor Therapeutics Inc
|
$20.80
|
$357.51M | - | 44 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$18.18
|
$354.45M | - | 61 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$31.95
|
$353.70M | - | 63 | Compare |
More ENTA Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry